MedTrace Logo

Renal Denervation in Patients With Chronic Heart Failure

NCT02085668 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-05-26

No results posted yet for this study

Summary

The purpose of the trial is to investigate the safety and effectiveness of renal denervation for the treatment of chronic heart failure (CHF).

Conditions

Interventions

DEVICE

Renal denervation (Symplicity™)

Delivery of radiofrequency through the wall of the renal artery to disrupt the surrounding renal nerves under angiography control

Sponsors & Collaborators

  • University Hospital, Saarland

    lead OTHER

Principal Investigators

  • Michael Böhm, MD · University Hospital, Saarland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-12-31
Completion
2019-05-31

Countries

  • Austria
  • Germany
  • Sweden
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02085668 on ClinicalTrials.gov